These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
454 related items for PubMed ID: 28974568
1. Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation: The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). Proietti M, Romiti GF, Olshansky B, Lip GYH. Hypertension; 2017 Nov; 70(5):949-958. PubMed ID: 28974568 [Abstract] [Full Text] [Related]
3. Systolic blood pressure visit-to-visit variability and outcomes in Asian patients with atrial fibrillation. Chichareon P, Methavigul K, Lip GYH, Krittayaphong R. Hypertens Res; 2024 Jun; 47(6):1479-1489. PubMed ID: 38438726 [Abstract] [Full Text] [Related]
4. Assessment of visit-to-visit variability in systolic blood pressure over 5 years and phasic left atrial function by two-dimensional speckle-tracking echocardiography. Tanaka S, Segawa T, Noda T, Tsugita N, Fuseya T, Kawaguchi T, Iwama M, Watanabe S, Minagawa T, Minatoguchi S, Hiroyuki O. Heart Vessels; 2021 Jun; 36(6):827-835. PubMed ID: 33462685 [Abstract] [Full Text] [Related]
5. Impact of Blood Pressure Visit-to-Visit Variability on Adverse Events in Patients With Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry. Kodani E, Inoue H, Atarashi H, Okumura K, Yamashita T, Otsuka T, Origasa H, J‐RHYTHM Registry Investigators *. J Am Heart Assoc; 2021 Jan 05; 10(1):e018585. PubMed ID: 33372541 [Abstract] [Full Text] [Related]
12. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Mancia G, Facchetti R, Parati G, Zanchetti A. Circulation; 2012 Jul 31; 126(5):569-78. PubMed ID: 22761453 [Abstract] [Full Text] [Related]
13. Systolic Blood Pressure Time in Target Range and Incident Atrial Fibrillation in Patients With Hypertension: Insights From the SPRINT Trial. Wang J, Jiang C, Li S, Wang Z, Wang Y, Lai Y, Wang Z, Lv W, Bai Y, Yang Z, Guo Q, Huang L, He L, Guo X, Li S, Liu N, Jiang C, Tang R, Long D, Du X, Sang C, Dong J, Ma C. Hypertension; 2023 Nov 31; 80(11):2306-2314. PubMed ID: 37589154 [Abstract] [Full Text] [Related]
19. Visit-to-visit variability in blood pressure and the development of chronic kidney disease in treated general hypertensive patients. Li Y, Li D, Song Y, Gao L, Fan F, Wang B, Liang M, Wang G, Li J, Zhang Y, Xu X, Hou FF, Cheng X, Sun N, Sun Y, Zhao L, Wan Q, Li X, Li J, Han Q, Xu X, Huo Y, Qin X. Nephrol Dial Transplant; 2020 Oct 01; 35(10):1739-1746. PubMed ID: 31102525 [Abstract] [Full Text] [Related]